Cerus Corporation
NASDAQ:CERSMedical - Devices
Healthcare
$1.90 +2.92%
+$0.08 today
- Market cap
- $383.71M
- Beta
- 1.77
- P/E (TTM)
- -53.8
- EPS (TTM)
- -$0.05
52W Low $1.15High $3.15
Volume 6.69M
Average 2.33M
Income Statement
Follow revenue through to earnings.
Revenue
$206.13M
FY 2025 · Annual
+14.3% YoYOperating Income
-$36.35M
FY 2025 · Annual
Net Income
-$15.63M
FY 2025 · Annual
Income Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 130.86M | 162.05M | 156.37M | 180.27M | 206.13M |
| Cost of Revenue | 63.48M | 74.95M | 69.97M | 80.75M | 95.85M |
| Gross Profit | 67.38M | 87.09M | 86.4M | 99.52M | 110.29M |
| Gross Margin | 51.5% | 53.7% | 55.3% | 55.2% | 53.5% |
| Research & Development | 63.69M | 64.11M | 67.64M | 58.91M | 65.72M |
| Selling, General & Admin | 81.29M | 83.34M | 75.52M | 75.89M | 80.91M |
| Operating Expenses | 116.32M | 121.18M | 116.45M | 113.75M | 146.63M |
| Depreciation & Amortization | 3.15M | 2.98M | 2.6M | 1.86M | 2M |
| EBITDA | (45.99M) | (33.52M) | (26.34M) | (10.02M) | (4.94M) |
| EBITDA Margin | -35.1% | -20.7% | -16.8% | -5.6% | -2.4% |
| Operating Income | (48.94M) | (34.08M) | (30.05M) | (14.23M) | (36.35M) |
| Operating Margin | -37.4% | -21.0% | -19.2% | -7.9% | -17.6% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 4.92M | 5.83M | 8.39M | 8.88M | 8.34M |
| Other Income / Expenses | (5.12M) | (8.26M) | (7.27M) | (6.53M) | 21.06M |
| Income Before Tax | (54.06M) | (42.34M) | (37.32M) | (20.76M) | (15.28M) |
| Pre-Tax Margin | -41.3% | -26.1% | -23.9% | -11.5% | -7.4% |
| Income Tax Expense | 319K | 488K | 325K | 205K | 354K |
| Net Income | (54.37M) | (42.78M) | (37.49M) | (20.92M) | (15.63M) |
| Net Margin | -41.6% | -26.4% | -24.0% | -11.6% | -7.6% |
| EPS (Basic) | (0.32) | (0.24) | (0.21) | (0.11) | (0.08) |
| EPS (Diluted) | (0.32) | (0.24) | (0.21) | (0.11) | (0.08) |
| 171.28M | 176.55M | 180.27M | 184.56M | 190.59M | |
| 171.28M | 176.55M | 180.27M | 184.56M | 190.59M |
CERS Earnings Waterfall · TTM
NASDAQ:CERS · Revenue to Net Income
Key Ratios
EPS$-0.05
Gross Margin54.3%
Net Margin-4.4%
P/E Ratio-1031.1
P/S Ratio5.9
Analysis
$222.8M of revenue converted into -$9.6M of net income for the selected period. Gross margin is 54.3% and net margin is -4.4%, showing how much revenue survives after costs and taxes. EPS is $-0.05, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G/A | SC 13G/A filing | Nov 13, 2026 | |
| S-3 | S-3 filing | Nov 2, 2026 | |
| 8-K | Current report | Nov 2, 2026 | |
| 10-Q | Quarterly report | Nov 2, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 17, 2026 |
How much revenue does CERS generate?
Cerus Corporation (CERS) reported $206.13M of revenue in fiscal 2025.
Is CERS profitable?
Cerus Corporation (CERS) reported -$15.63M of net income, with a net margin of -7.6%.
Continue the stock analysis
Jump to another research area for this company.